Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer.

Taïeb, J; Artru, P; Baujat, B; Mabro, M; Carola, E; Maindrault, F; Tournigand, C; Krulik, M; Louvet, C; de Gramont, A

Taïeb, J; Artru, P; Baujat, B; Mabro, M; Carola, E; Maindrault, F; Tournigand, C; Krulik, M; Louvet, C; de Gramont, A.

Affiliation

Taïeb J; Médecine Interne-Oncologie, Hôpital St-Antoine, 184 rue du faubourg Saint-Antoine, 75571 Paris cedex 12, France. jtaieb@club-internet.fr

Eur J Cancer ; 38(5): 661-6, 2002 Mar.

Article in En | MEDLINE | ID: mdl-11916548

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Esophageal Neoplasms / Carcinoma, Squamous Cell / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2002 Document type: Article Affiliation country: Francia Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links